Insights on the molecular mechanisms of cytotoxicity induced by AS1411 linked to folate-functionalized DNA nanocages in cancer cells
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Insights on the molecular mechanisms of cytotoxicity induced by AS1411 linked to folate-functionalized DNA nanocages in cancer cells
Authors
Keywords
-
Journal
Nanomedicine-Nanotechnology Biology and Medicine
Volume 54, Issue -, Pages 102710
Publisher
Elsevier BV
Online
2023-09-20
DOI
10.1016/j.nano.2023.102710
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Folate-Functionalization Enhances Cytotoxicity of Multivalent DNA Nanocages on Triple-Negative Breast Cancer Cells
- (2022) Valeria Unida et al. Pharmaceutics
- Combined and selective miR-21 silencing and doxorubicin delivery in cancer cells using tailored DNA nanostructures
- (2021) Sofia Raniolo et al. Cell Death & Disease
- DNA Nanostructures: Current Challenges and Opportunities for Cellular Delivery
- (2021) Aurélie Lacroix et al. ACS Nano
- The Role of Early Growth Response Family Members 1–4 in Prognostic Value of Breast Cancer
- (2021) Leiyu Hao et al. Frontiers in Genetics
- AS1411 Aptamer Linked to DNA Nanostructures Diverts Its Traffic Inside Cancer Cells and Improves Its Therapeutic Efficacy
- (2021) Giulia Vindigni et al. Pharmaceutics
- Delivery of thymoquinone to cancer cells with as1411-conjugated nanodroplets
- (2020) Emily M. Murphy et al. PLoS One
- LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis
- (2020) Niansheng Ren et al. Aging-US
- Differential regulation of Lipocalin 2 (LCN2) in doxorubicin-resistant 4T1 triple negative breast cancer cells
- (2020) Steffen K. Meurer et al. CELLULAR SIGNALLING
- Master Regulator Activating Transcription Factor 3 (ATF3) in Metabolic Homeostasis and Cancer
- (2020) Hui-Chen Ku et al. Frontiers in Endocrinology
- Designer DNA nanostructures for therapeutics
- (2020) Shuoxing Jiang et al. Chem
- SIRT1 downregulated FGB expression to inhibit RCC tumorigenesis by destabilizing STAT3
- (2019) Yanbing Chen et al. EXPERIMENTAL CELL RESEARCH
- LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis
- (2019) Er-lin Song et al. Aging-US
- MT2A is an early predictive biomarker of response to chemotherapy and a potential therapeutic target in osteosarcoma
- (2019) Adèle Mangelinck et al. Scientific Reports
- Mutation of the PTCH1 gene predicts recurrence of breast cancer
- (2019) Chih-Yang Wang et al. Scientific Reports
- In Silico and In Cell Analysis of Openable DNA Nanocages for miRNA Silencing
- (2019) Sofia Raniolo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Selective targeting and degradation of doxorubicin-loaded folate-functionalized DNA nanocages
- (2018) Sofia Raniolo et al. Nanomedicine-Nanotechnology Biology and Medicine
- Entry, fate and degradation of DNA nanocages in mammalian cells: a matter of receptors
- (2018) Sofia Raniolo et al. Nanoscale
- Rewiring of cisplatin-resistant bladder cancer cells through epigenetic regulation of genes involved in amino acid metabolism
- (2018) Austin Yeon et al. Theranostics
- A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer
- (2017) Fangfei Li et al. Nature Communications
- Receptor-Mediated Entry of Pristine Octahedral DNA Nanocages in Mammalian Cells
- (2016) Giulia Vindigni et al. ACS Nano
- DNA nanovehicles and the biological barriers
- (2016) Anders H. Okholm et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeting folate receptor alpha for cancer treatment
- (2016) Anthony Cheung et al. Oncotarget
- Wnt5a Signaling in Cancer
- (2016) Marwa Asem et al. Cancers
- AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin
- (2016) Ye Cheng et al. PLoS One
- The roles of nucleolin subcellular localization in cancer
- (2015) Caroline Madeleine Berger et al. BIOCHIMIE
- HTSeq--a Python framework to work with high-throughput sequencing data
- (2014) S. Anders et al. BIOINFORMATICS
- A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
- (2013) Jonathan E. Rosenberg et al. INVESTIGATIONAL NEW DRUGS
- Zinc chelation: a metallothionein 2A’s mechanism of action involved in osteosarcoma cell death and chemotherapy resistance
- (2013) N Habel et al. Cell Death & Disease
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Arsenic Trioxide (ATO) Influences the Gene Expression of Metallothioneins in Human Glioblastoma Cells
- (2012) Ingrid Falnoga et al. BIOLOGICAL TRACE ELEMENT RESEARCH
- Proteomic Analysis of Glioma Chemoresistance
- (2012) Kyoungho Suk Current Neuropharmacology
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
- (2012) Guangchuang Yu et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Structure of Nanoscale Truncated Octahedral DNA Cages: Variation of Single-Stranded Linker Regions and Influence on Assembly Yields
- (2010) Cristiano Luis Pinto Oliveira et al. ACS Nano
- Deciphering the Structural Properties That Confer Stability to a DNA Nanocage
- (2009) Mattia Falconi et al. ACS Nano
- Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
- (2009) Paula J. Bates et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Down-regulation of lipocalin 2 contributes to chemoresistance in glioblastoma cells
- (2009) Long Tai Zheng et al. JOURNAL OF NEUROCHEMISTRY
- The Nucleolin Targeting Aptamer AS1411 Destabilizes Bcl-2 Messenger RNA in Human Breast Cancer Cells
- (2008) S. Soundararajan et al. CANCER RESEARCH
- Over-expression of metallothionein predicts chemoresistance in breast cancer
- (2008) Xinli Yap et al. JOURNAL OF PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started